Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|September 16, 2005
Engineering stable peptide toxins by means of backbone cyclization: stabilization of the alpha-conotoxin MIIRichard J Clark, Harald Fischer, Louise Dempster, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 18, 2000
A pilot study evaluating ceftriaxone and penicillin G as treatment agents for neurosyphilis in human immunodeficiency virus-infected individualsC M Marra, P Boutin, J C McArthur, et al.
Journal of Neurochemistry|September 18, 2008
Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor functionAndre L Samson, Simon T Nevin, David Croucher, et al.
BMC Structural Biology|April 21, 2007
Structure of alpha-conotoxin BuIA: influences of disulfide connectivity on structural dynamicsAi-Hua Jin, Hemma Brandstaetter, Simon T Nevin, et al.
Antimicrobial Agents and Chemotherapy|May 29, 1999
ACTG 260: a randomized, phase I-II, dose-ranging trial of the anti-human immunodeficiency virus activity of delavirdine monotherapy. The AIDS Clinical Trials Group Protocol 260 TeamM F Para, P Meehan, J Holden-Wiltse, et al.
Journal of Medicinal Chemistry|August 30, 2008
Molecular engineering of conotoxins: the importance of loop size to alpha-conotoxin structure and functionAi-Hua Jin, Norelle L Daly, Simon T Nevin, et al.
The Journal of Biological Chemistry|December 23, 2008
Inhibition of neuronal nicotinic acetylcholine receptor subtypes by alpha-Conotoxin GID and analoguesEmma L Millard, Simon T Nevin, Marion L Loughnan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 14, 2000
Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus GroupM P Dubé, D Sprecher, W K Henry, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|June 1, 1996
Pilot study of topical trifluridine for the treatment of acyclovir-resistant mucocutaneous herpes simplex disease in patients with AIDS (ACTG 172). AIDS Clinical Trials GroupH A Kessler, S Hurwitz, C Farthing, et al.
Antiviral Research|October 23, 2004
A phase II, double-masked, randomized, placebo-controlled evaluation of a human monoclonal anti-Cytomegalovirus antibody (MSL-109) in combination with standard therapy versus standard therapy alone in the treatment of AIDS patients with Cytomegalovirus retinitisMichael J Borucki, John Spritzler, David M Asmuth, et al.
Pageof 5